FindTrial
Sign In

To study the efficacy of Yavanikhandav Churna in the management of Pandu Vyadhi with special reference to Iron Deficiency Anemia in children between age group 1 to 12 year

Randomized controlled trial to evaluate the efficacy of Yavanikhandav Churna in the management of Pandu Vyadhi with special reference to Iron Deficiency Anemia in children. - NIL

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2025/01/079799
Enrollment
90
Registered
2025-01-30
Start date
Unknown
Completion date
Unknown
Last updated
2025-03-03

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: D509- Iron deficiency anemia, unspecified

Interventions

None listed

Sponsors

Sane Guruji Arogya Kendra
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: 1. Iron Deficency Anemia Diagnosed patients will be included 2. Patients between Hb 09 to12 gm per dl. 3. Patient between the age group of 1 to 12 years will be taken. 4. Primarily the patients will be selected on the basis of Hb percentages found in laboratory investigations also classical symptoms of Pandu Roga. 5. Patients having any 5 or more than 5 lakashanas of the following will be enrolled in the study Panduta (Pallor) Shrama (Reduced exercise capacity) Gatrasada (Fatigue) Gatrashoola (Bodyache) Shwasa (Breathlessness) Hridyaspandana (Palpitation) Aalasya (Drowsiness) Shiroruja (Headache) Aruchi (Anorexia) Dourbalya (Weakness) Akshikut soth (Eye swelling) Karnashweda(Tinitus)

Exclusion criteria

Exclusion criteria: 1. Drug Allergy 2. Hb less than 9 mg per dl 3. Systemic Diseases 4. Bleeding Disorder 5. Those who are not willing to participate in trial and not ready to give written consent.

Design outcomes

Primary

MeasureTime frame
To evaluate the efficacy of Yavanikhandav Churna in the management of Pandu Vyadhi with special reference to Iron Deficiency Anemia in childrenTimepoint: Treatment will be given for 30 days.Ferrous ascorbate will be given to one group and yavanikhandav churna will be given to another group. Followup will be taken on 7th 15th and 30th day. Assesment will be done by objective and subjective parameters. Final observation will be recorded after completion of treatment.—

Secondary

MeasureTime frame
Litrature Study of Pandu in Paediatric age group. To observe the adverse effect if anyTimepoint: Study will be done using the ayurvedic granthas and modern text. Preparation of drugs will be done according to standard procedure. During treatment observation will be done on 7th, 15th and 30th day.—

Countries

India

Contacts

Public ContactDr Ramchandra Pnadurang Babar

MAM S Sumatibhai Shah Ayurved Mahavidyalaya Malwadi Hadapsar Pune

ramchandrababar@gmail.com8275459237

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026